What should you know about superficial mcl?

Morphea is also called localised scleroderma. Superficial areas may look pink, purple, lighter, or darker than nearby skin and can gradually feel firmer or smoother. The condition is limited to defined areas rather than being the same as systemic scleroderma. A clinician may diagnose it from the examination and occasionally a skin biopsy.

The active edge can look different from the centre. Some patches become quiet and leave altered colour or texture after inflammation settles. The effect depends on the site, activity, and depth of involvement.

Arrange review if a patch is expanding, changing colour, becoming firm, or restricting movement near a joint. Use gentle cleansing and regular moisturiser, and avoid harsh scrubbing or unadvised steroid mixtures. Keep photographs with dates so the clinician can compare the border over time.

Treatment is selected according to activity and depth. A clinician may discuss topical calcineurin inhibitors for suitable superficial areas; see Topical Calcineurin Inhibitors. Narrowband UVB Phototherapy may be considered for selected widespread superficial disease when a specialist feels it is appropriate.

Seek a timely appointment for rapid expansion, new pain, warmth, ulceration, or involvement around an eye, mouth, or joint. Contact a clinician sooner if tightening makes movement difficult. Urgent assessment is appropriate for fever with rapidly spreading redness, severe pain, or marked swelling, because infection or another process may need prompt treatment.

Ask whether the patches are active, whether a biopsy is useful, what treatment area and duration are expected, and how to protect nearby skin. Discuss how movement, colour change, or relapse will be monitored and when a review should occur.